Clinical assessment of peripheral muscle function in patients with chronic obstructive pulmonary disease

American Journal of Physical Medicine and Rehabilitation

Volumn 88, Issue 1, 2009, Pages 39-46

  Vilaro, Jordi ^b,e   Rabinovich, Roberto ^a   Gonzalez deSuso, Jose Manuel ^c   Troosters, Thierry ^d   Rodríguez, Diego ^a   Barberà, Joan Albert ^a   Roca, Josep ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT RAMON LLULL   (Spain)

^c Centre d'Alt Rendiment Esportiu   (Spain)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

Body mass index; COPD; Endurance; Exercise testing; Muscle strength; Thigh muscle mass

Indexed keywords

CREATINE PHOSPHATE; OXYGEN;

ADULT; AGED; ARTICLE; BIOENERGY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDURANCE; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; MUSCLE EXERCISE; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE STRENGTH; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; QUADRICEPS FEMORIS MUSCLE; THIGH; BODY MASS; CASE CONTROL STUDY; EXERCISE TEST; LUNG FUNCTION TEST; MIDDLE AGED; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; SKELETAL MUSCLE;

AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; EXERCISE TEST; EXERCISE TOLERANCE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE STRENGTH; MUSCLE, SKELETAL; PHYSICAL ENDURANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; THIGH;

EID: 58249092248     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/PHM.0b013e31818dff86     Document Type: Article

References (45)

1. American Thoracic Society and European Respiratory Society: Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:s1-s40
2. Whittom F, Jobin J, Simard PM, et al: Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 1998;30: 1467-74
3. Bernard S, Leblanc P, Whittom F, et al: Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:629-34
4. Hare JM: Nitroso-redox balance in the cardiovascular system. N Engl J Med 2004;351:2112-14
5. Gosselink R, Troosters T, Decramer M: Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996;153: 976-80
6. Celli B: The COPD staging system (SCORE) combining 6MWT, FEV1, MRC dyspnea and BMI is a better predictor of mortality than FEV1. Am J Respir Crit Care Med 2001;163:A504
7. Hopkinson NS, Tennant RC, Dayer MJ, et al: A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res 2007;13:8-25
8. Decramer M, Gosselink LE, Troosters T, et al: Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J 1997;10: 417-23
9. Marquis K, Debigare R, Lacasse Y, et al: Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:809-13
10. Heijdra YF, Pinto-Plata V, Frants R, et al: Muscle strength and exercise kinetics in COPD patients with a normal fat-free mass index are comparable to control subjects. Chest 2003;124:75-82
11. Sala E, Roca J, Marrades RM, et al: Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:1726-34
12. Richardson RS, Leek BT, Gavin TP, et al: Reduced mechanical efficiency in chronic obstructive pulmonary disease but normal peak V02 with small muscle mass exercise. Am J Respir Crit Care Med 2004;169: 89-96
13. Rabinovich RA, Bastos R, Ardite E, et al: Mitochondrial dysfunction in COPD patients with low body mass index. Eur Respir J 2007;29:643-50
14. Maltais F, Simard AA, Simard C, et al: Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 1996; 153:288-93
15. Couillard A, Maltais F, Saey D, et al: Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in COPD patients. Am J Respir Crit Care Med 2003;167:1664-9
16. Allaire J, Maltais F, Doyon JF, et al: Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax 2004;59:673-8
17. Coronell C, Orozco-Levi M, Mendez R, et al: Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J 2004;24:129-36
18. Koechlin C, Couillard A, Simar D, et al: Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2004;169:1022-7
19. Roca J, Burgos F, Sunyer J, et al: References values for forced spirometry. Eur Respir J 1998;11:1354-62
20. Roca J, Burgos F, Barberà JA, et al: Prediction equations for plethysmografic lung volumes. Respir Med 1998;92:454-60
21. Neder JA, Nery LE, Shinzato GT, et al: Reference values for concentric knee isokinetic strength and power in nonathletic men and women from 20 to 80 years old. J Orthop Sports Phys Ther 1999;29:116-26
22. Pincivero DM, Lephart SM, Karunakara RA: Reliability and precision of isokinetic strength and muscular endurance for the quadriceps and hamstrings. Int J Sports Med 1997;18:113-17
23. Mathiowetz V, Kashman N, Volland G, et al: Grip and pinch strength: Normative data for adults. Arch Phys Med Rehabil 1985;66:69-74
24. 31P-NMR spectroscopy inside a standard NMR scanner. Magn Reson Med 1993;29:575-81
25. Marrades RM, Alonso J, Roca J, et al: Cellular bioenergetics after erythropoietin therapy in chronic renal failure. J Clin Invest 1996;97:2101-10
26. Janssen YJ, Doornbos J, Roelfsema F: Changes in muscle volume, strength, and bioenergetics during recombinant human growth hormone (GH) therapy in adults with GH deficiency. J Clin Endocrinol Metab 1999;84:279-84
27. Roberts N, Cruz-Orive LM, Reid N, et al: Unbiased estimation of whole body composition in man by Cavalieri's method using magnetic resonance imaging. J Microscop 1993;171:239-53
28. Tracy BL, Ivey FM, Hurlbut D, et al: Muscle quality. II. Effects Of strength training in 65 to 75-yr-old men and women. J Appl Physiol 1999;86:195-201
29. Bangsbo J, Gollnick PD, Graham TE, et al: Substrates for muscle glycogen synthesis in recovery from intense exercise in man. J Physiol 1990;40:423-40
30. Mungiole M, Martin PE: Estimating segment inertial properties: Comparison of magnetic resonance imaging with existing methods. J Biomechanics 1990; 10:1039-46
31. Roca J, Weisman IM, Palange P, et al: Clinical exercise testing, in Roca J, Whipp B (eds): European Respiratory Monograph, vol 2, chapter 5. Sheffield, UK, European Respiratory Society Journals Ltd, 1997, pp 88-114
32. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories: ATS statement: Guidelines for the six-minute walk test Am J Respir Crit Care Med 2002;166:111-17
33. Debigare R, Cote CH, Hould FS, et al: In vitro and in vivo contractile properties of the vastus lateralis muscle in males with COPD. Eur Respir J 2003;21: 273-8
34. Couillard A, Prefaut C: From muscle disuse to myopathy in COPD: Potential contribution of oxidative stress. Eur Respir J 2005;26:703-19
35. Serres I, Gautier V, Varray A, et al: Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest 1998; 113:900-5
36. Haseler LJ, Kindig CA, Richardson RS, et al: The role of oxygen in determining phosphocreatine onset kinetics in exercising humans. J Physiol 2004;558: 985-92
37. 2 availability. J Appl Physiol 1999;86:2013-18
38. Celli BR, Cote CG, Marin JM, et al: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12
39. Mador MJ: Muscle mass, not body weight, predicts outcome in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166:787-9
40. Schols AMWJ, Soeters PB, Dingemans AMC, et al: Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993;147: 1151-6
41. Kotler DP, Burastero S, Wang J, et al: Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: Effects of race, sex, and disease. Am J Clin Nutr 1996;64:489s-497s
42. Schols AM, Wouters EF, Soeters PB, et al: Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1991;53:421-4
43. Vestbo J, Prescott E, Almdal T, et al: Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: Findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006;173:79-83
44. Troosters T, Vilaro J, Rabinovich R, et al: Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease. Eur Respir J 2002;20:564-9
45. Casas A, Vilaro J, Rabinovich R, et al: Encouraged 6-min walking test indicates maximum sustainable exercise in COPD patients. Chest 2005;128:55-61